Download full report with analyst certification and important disclosures
May 29 2018, 10:50 IST/BST
Glanbia’s Capital Markets Day, which took place at its Downers Grove Innovation Centre in Illinois, showcased an ambitious and relevant business at the centre of dynamic consumer trends. New five-year targets (2018-2022) strike a healthy balance between growth, capital discipline and cash conversion. The targets reflect a group that anticipates growth through both organic measures and selective M&A – the latter expected to be tilted towards the Nutritional Solutions (NS) business. The next phase of growth will be about revenue development and capital allocation. Historic execution gives Glanbia licence to look forward with confidence.